SEC Form D private-offering filing
Indapta Therapeutics Inc.
A new SEC Form D private-offering notice from Houston, TX, a $51,574,072 filer-stated offering target in Biotech. The source filing is one click away.
Develops an off the shelf, allogeneic g-NK natural killer cell therapy platform for cancer and autoimmune diseases, with lead candidate IDP-023 in Phase 1 trials for lymphoma, multiple myeloma and progressive multiple sclerosis.
Filed 2025-10-14Filed to raise $51,574,072First money in 2025-09-24Raised so far $50,800,176HQ (as filed) Houston, TXSector Biotech ✓Stage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified indapta.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.